Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Active, not recruiting · NCT03399799 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Active, not recruiting | Phase 1 | 2026-09-25 | NCT03399799 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Research & Development, LLC | 188 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman | Liège | Belgium | 8 |
| City of Hope | Duarte | United States | 238 |
| Clinica Univ. de Navarra | Pamplona | Spain | 42 |
| Hosp Clinico Univ de Salamanca | Salamanca | Spain | 34 |
| Hosp Univ Fund Jimenez Diaz | Madrid | Spain | 33 |
| Hosp. Quiron Madrid Pozuelo | Pozuelo de Alarcón | Spain | 15 |
| Hosp. Univ. Germans Trias I Pujol | Badalona | Spain | 28 |
| Mount Sinai Medical Center | New York | United States | 40 |
| Tennessee Oncology | Nashville | United States | 77 |
| UMCU | Utrecht | Netherlands | 3 |
| University of Alabama Birmingham | Birmingham | United States | 20 |
| University of Colorado Cancer Center | Aurora | United States | 63 |
| VU Medisch Centrum | Amsterdam | Netherlands | 16 |